2009
DOI: 10.1371/journal.ppat.1000350
|View full text |Cite
|
Sign up to set email alerts
|

Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses

Abstract: The hemagglutinin (HA) of influenza A viruses has been classified into sixteen distinct subtypes (H1–H16) to date. The HA subtypes of influenza A viruses are principally defined as serotypes determined by neutralization or hemagglutination inhibition tests using polyclonal antisera to the respective HA subtypes, which have little cross-reactivity to the other HA subtypes. Thus, it is generally believed that the neutralizing antibodies are not broadly cross-reactive among HA subtypes. In this study, we generate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
196
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 186 publications
(203 citation statements)
references
References 47 publications
5
196
0
1
Order By: Relevance
“…This change was present in all contact quail. It is interesting that both the N155D and K151E adaptive mutations in this region of the HA are located at the globular head and within the I-A antigenic site (site B in H3) (41,46). Therefore, given the other five adaptive changes, the quail were able to support a mutation near the original mutation site, indicating its importance in supporting transmission in quail.…”
Section: Resultsmentioning
confidence: 99%
“…This change was present in all contact quail. It is interesting that both the N155D and K151E adaptive mutations in this region of the HA are located at the globular head and within the I-A antigenic site (site B in H3) (41,46). Therefore, given the other five adaptive changes, the quail were able to support a mutation near the original mutation site, indicating its importance in supporting transmission in quail.…”
Section: Resultsmentioning
confidence: 99%
“…per cell at 37°C. The amount of infectious virus in culture supernatants was determined with a plaque assay as described previously 66,67 . Briefly, confluent monolayers of MDCK cells in 12-well plates were inoculated with the supernatants.…”
Section: Discussionmentioning
confidence: 99%
“…The neutralizing activity of VLP-immunized mouse sera was measured by plaque reduction assay using MDCK cells, as described previously (40). Serum diluted 1:13 was mixed with 100 PFU of influenza virus A/PR/8/34, and the mixture was incubated (1 h, 37°C).…”
Section: Dot Blot Assay Purified Uv-inactivated Influenza Virus (4 mentioning
confidence: 99%